4//SEC Filing
Ellis Christopher 4
Accession 0001104659-22-095142
CIK 0001828185other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 4:26 PM ET
Size
17.2 KB
Accession
0001104659-22-095142
Insider Transaction Report
Form 4
Vaccitech plcVACC
Ellis Christopher
Chief Operating Officer
Transactions
- Sale
Ordinary Shares
2022-08-25$7.07/sh−25,000$176,708→ 75 total - Exercise/Conversion
Ordinary Shares
2022-08-24$0.00/sh+450$0→ 525 total - Sale
Ordinary Shares
2022-08-24$4.78/sh−450$2,152→ 75 total - Exercise/Conversion
Ordinary Shares
2022-08-25$0.00/sh+39,176$16→ 39,251 total - Exercise/Conversion
Share Option (Right to Buy)
2022-08-24−450→ 40,156 totalExercise: $0.00Exp: 2028-02-16→ Ordinary Shares (450 underlying) - Sale
Ordinary Shares
2022-08-25$5.69/sh−14,176$80,688→ 25,075 total - Exercise/Conversion
Share Option (Right to Buy)
2022-08-25−39,176→ 980 totalExercise: $0.00Exp: 2028-02-16→ Ordinary Shares (39,176 underlying)
Footnotes (5)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 - $4.96. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.46 - $5.93. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.04 - $7.12. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]This option is fully vested and exercisable as of the date hereof. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.
Documents
Issuer
Vaccitech plc
CIK 0001828185
Entity typeother
Related Parties
1- filerCIK 0001851664
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 4:26 PM ET
- Size
- 17.2 KB